Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The investigators will prospectively enroll 30 neonatal and pediatric ECMO patients at a
single pediatric Level 1 trauma center. The patients will be randomized into two arms; one
arm will receive unfractionated heparin and the other arm will receive bivalirudin. There
will be 15 patients in each arm for a total of 30 patients.
Primary aim will be to compare the efficacy of bivalirudin to unfractionated heparin.